Here ’s how Eli Lilly might bring a game-changing Alzheimer’s drug to market

As part of the MarketWatch 50 series, Eleanor Laise interviewed Dr. Daniel Skovronsky, the chief scientific and medical officer at Eli Lilly & Co. LLY, . The company’s stock has soared 63% this year amid excitement for its Mounjaro treatment for Type 2 diabetes. This is a GLP-1 medication,…#marketwatch50 #eleanorlaise #danielskovronsky #elilillyco #lly #mounjaro #glp1 #wegovyandozempic #novonordiskasnvo #lilly
Source: Reuters: Health - Category: Consumer Health News Source Type: news